| Bioactivity | O-GlcNAcase-IN-4 is a O-GlcNAcase inhibitor extracted from patent WO2018140299A1 Formulaic Ic. O-GlcNAcase-IN-4 can be used for the research of neurodegenerative diseases and disorders, such as Alzheimer's disease[1]. |
| Target | O-GlcNAcase |
| Name | O-GlcNAcase-IN-4 |
| CAS | 2241514-58-7 |
| Formula | C16H22FN5O3S |
| Molar Mass | 383.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dreyfus NJF, et, al. N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor. WO2018140299A1. |
O-GlcNAcase-IN-4
CAS: 2241514-58-7 F: C16H22FN5O3S W: 383.44
O-GlcNAcase-IN-4 is a O-GlcNAcase inhibitor extracted from patent WO2018140299A1 Formulaic Ic. O-GlcNAcase-IN-4 can be u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.